EYES is Corgi Data & Surveillance ETF (Healthcare) — a non-dividend-paying stock. Trading at $28.51. Capital Quality Rank: 85/100 — Elite compounder.
Stock snapshot
| Price | $28.51 |
| Market cap | — |
| Sector | Healthcare |
| Exchange | BTS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 85 / 100 · Elite compounder |
| Shareholder buyback yield | 0.00% |
| Altman Z-score zone | Safe |
Related non-dividend companies
Other non-dividend stocks investors research alongside EYES. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is EYES's current stock price?
EYES (Corgi Data & Surveillance ETF) is currently trading at $28.51.
Does EYES pay a dividend?
EYES (Corgi Data & Surveillance ETF) does not currently pay a regular dividend.
What is EYES's Capital Quality Rank?
EYES has a Capital Quality Rank of 85/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track EYES in DiviDrip
Add EYES to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search EYES and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.